We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$39.1B
AUM Growth
+$2.42B
Cap. Flow
-$248M
Cap. Flow %
-0.63%
Top 10 Hldgs %
22.64%
Holding
3,845
New
218
Increased
1,110
Reduced
1,483
Closed
148

Sector Composition

Rank Sector Weight
1 Technology 11.27%
2 Financials 10.78%
3 Industrials 9.91%
4 Healthcare 9.19%
5 Consumer Staples 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MHF
3276
Western Asset Municipal High Income Fund
MHF
$151M
$5K ﹤0.01%
713
-6,099
-90% -$46.4K
NCA icon
3277
Nuveen California Municipal Value Fund
NCA
$299M
$5K ﹤0.01%
500
OFIX icon
3278
Orthofix Medical
OFIX
$455M
$5K ﹤0.01%
109
-73
-40% -$3.43K
PFD
3279
Flaherty & Crumrine Preferred and Income Fund
PFD
$145M
$5K ﹤0.01%
300
BCIC
3280
BCP Investment Corp
BCIC
$86.9M
$5K ﹤0.01%
+250
New +$5.39K
QUS icon
3281
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.52B
$5K ﹤0.01%
52
RXI icon
3282
iShares Global Consumer Discretionary ETF
RXI
$245M
$5K ﹤0.01%
40
SBI
3283
Western Asset Intermediate Muni Fund
SBI
$109M
$5K ﹤0.01%
526
-5,399
-91% -$49.6K
SPIB icon
3284
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
$5K ﹤0.01%
145
-7,722
-98% -$272K
SPRO icon
3285
Spero Therapeutics
SPRO
$68.9M
$5K ﹤0.01%
500
SPTS icon
3286
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.07B
$5K ﹤0.01%
165
TGB
3287
Trekor Metals
TGB
$2.56B
$5K ﹤0.01%
10,200
TVTX icon
3288
Travere Therapeutics
TVTX
$5.33B
$5K ﹤0.01%
311
+101
+48% +$1.29K
TYG
3289
Tortoise Energy Infrastructure Corp
TYG
$1.14B
$5K ﹤0.01%
72
-151
-68% -$11.1K
UPWK icon
3290
Upwork
UPWK
$1.09B
$5K ﹤0.01%
500
URGN icon
3291
UroGen Pharma
URGN
$2B
$5K ﹤0.01%
147
+11
+8% +$300
UXIN
3292
Uxin Ltd
UXIN
$330M
$5K ﹤0.01%
+22
New +$5.95K
VRTS icon
3293
Virtus Investment Partners
VRTS
$1.11B
$5K ﹤0.01%
38
-168
-82% -$18.7K
TBCH
3294
Turtle Beach Corp
TBCH
$239M
$5K ﹤0.01%
500
LL
3295
DELISTED
LL Flooring Holdings, Inc.
LL
$5K ﹤0.01%
485
+465
+2,325% +$4.35K
NXGN
3296
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$5K ﹤0.01%
324
AERI
3297
DELISTED
Aerie Pharmaceuticals
AERI
$5K ﹤0.01%
220
-61
-22% -$1.26K
LOGC
3298
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$5K ﹤0.01%
+750
New +$6.78K
CFMS
3299
DELISTED
Conformis, Inc. Common Stock
CFMS
$5K ﹤0.01%
120
+80
+200% +$3.79K
RDUS
3300
DELISTED
Radius Health, Inc.
RDUS
$5K ﹤0.01%
258

Similar funds

US Bancorp's Q4 2019 Portfolio in Review

As of Q4 2019, US Bancorp held 3,845 positions worth $39.1B, up 6.6% from $36.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q4 2019 filing shows 218 new, 1,110 increased, 1,483 reduced and 148 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M. The largest sale was Celgene Corp, an estimated $80.2M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Industrials.

  • US Bancorp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 611,031 shares worth $1.84M.
  • US Bancorp added most to iShares Russell Mid-Cap ETF in Q4 2019, an estimated $45.6M increase.
  • US Bancorp's biggest Q4 2019 reduction was Copart, cutting an estimated $55.9M.
  • US Bancorp fully exited Celgene Corp in Q4 2019, selling an estimated $80.2M.
  • US Bancorp's ten largest holdings make up 23% of its $39.1B portfolio in Q4 2019.
  • US Bancorp opened 218 new positions and closed 148 in Q4 2019.
  • US Bancorp's portfolio value rose 6.6% quarter-over-quarter to $39.1B.

Based on US Bancorp's 13F filing for Q4 2019, filed 4 Feb 2020.